Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population

Author:

Malhotra Sankalp,Hyer J. Madison,Dalmacy Djhenne,Hayes Don,Tumin Dmitry,Kirkby Stephen E,Jonas Daniel E,Bose-Brill SeuliORCID,Li Susan S.ORCID

Publisher

Elsevier BV

Reference56 articles.

1. Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world - opportunities and challenges;Barry;Curr Opin Pulm Med,2021

2. Future trends in cystic fibrosis demography in 34 European countries;Burgel;Eur Respir J,2015

3. Cystic Fibrosis Foundation Patient Registry,2021

4. The changing face of cystic fibrosis in the era of precision medicine;Modulators;Front Pharmacol,2020

5. CFTR modulator therapies – effect on life expectancy in people with cystic fibrosis;Balfour-Lynn;Paediatr Respir Rev,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3